Citi analyst Patrick Donnelly launched a “90-day negative catalyst watch” on Avantor heading into the Q2 earnings. The firm sees further downside risk to the company’s fiscal 2023 guidance citing the currently implied bioproduction growth guidance ramp for the remainder of the year and subsequent readthrough from industry peers on various headwinds including inventory destocking impacting both laboratory consumables and consumables within bioproduction.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AVTR: